// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Distal Transradial Approach for Coronary Procedures: A Meta-Analysis of Randomized Controlled Trials

Mohamed Hamed - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Hematoma

N/A

Predictors of Cross-Over for Distal Radial Access: Insights From the DISCO RADIAL Study

Adel Aminian - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of Arterial Access Site for Coronary Intravascular Lithotripsy Treatment of Severely Calcified Coronary Lesions: A Patient-Level Pooled Analysis of the Disrupt CAD III and CAD IV Studies

Richard Shlofmitz - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Comparison of Vascular Closure Devices and Techniques in Transcatheter Aortic Valve Replacement

Jonathan Mailey - Transcatheter Cardiovascular Therapeutics (TCT) , 2022

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Cardiac power and power reserve are impaired in asymptomatic patients with aortic stenosis and associated with exercise capacity

Muhammad Haris - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Aortic stenosis

N/A

Genotype-specific clinical and imaging characteristics of novel rare truncating variants associated with dilated and arrhythmogenic cardiomyopathy

Momina Yazdani - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Arrhythmogenic right ventricular cardiomyopathy

N/A

Understanding cardiac and sudden death in young individuals: novel insights from the office for national statistics (ONS) in the United Kingdom

Raghav Bhatia - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Structural Heart Disease

N/A

Cardiac care study: the effect of esc 2022 cardio-oncology guidelines on this cohort

Krithika Loganath - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Congestive heart failure

Doxorubicin

Screening for and monitoring fontan-associated liver disease in a tertiary centre

Panagiota Mitropoulou - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Fontan failure

N/A

A validated model for the prediction of adverse cardiac outcome in patients with fabry disease derived from readily available clinical data

Chris Orsborne - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Fabry disease

N/A

The incidence of co-morbid medical conditions amongst patients with aortic stenosis

Khalda Halim - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Chronic obstructive pulmonary disease

N/A

Case report: a new diagnosis of heterotaxy syndrome with left isomerism and pulmonary hypertension in an older adult

Jack Harfield - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interrupted inferior vena cava

N/A

Initial clinical experience with 6-hour enoxaparin regimen in opiate-treated patients undergoing primary percutaneous coronary intervention

Nadir Elamin - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Blood/haematological Diseases

Venous thrombosis

Heparin

Investigation of the effects of dietary nitrate on vascular function, platelet reactivity and restenosis in patients with stable angina (nitrate-oct study)

Krishnaraj Rathod - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Restenosis

Nitric oxide

An analysis of the virtual cardio-oncology research initiative (VICORI) resource: bleeding risk among acute coronary syndrome patients with cancer

Kok Weng Ow - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Does FFR-guided PCI result in improved absolute coronary blood flow?

Abdulaziz Albaraikan - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Angina

N/A

Comparing pressure-bound coronary flow reserve versus thermodilution-derived coronary flow reserve

Daniel Ang - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Insights from positron emission tomography into the mechanism of the coronary sinus reducer

Kevin Cheng - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The role of angiography-derived (VIRTUAL) fractional flow reserve in the management of patients with acute coronary syndromes (ACS); the VIRTU4-ACS study

Hazel Haley - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Acute Coronary Syndromes

N/A

Elevated troponin during hospital admission with infection associated with increased short and long-term mortality

Amit Kaura - British Cardiovascular Society (BCS) , 2023

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved